Par Pharmaceutical: Endo International plc: Endo Launches Colchicine Capsules, Generic Version of MITIGARE
DUBLIN, Nov. 2, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., has begun shipping colchicine 0.6 mg capsule...
Read full article »
CEO
Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States.
Read more